BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 30101708)

  • 1. Deformation-based Statistical Shape Analysis of the Corpus Callosum in Mild Cognitive Impairment and Alzheimer's Disease.
    Jiang Z; Yang H; Tang X
    Curr Alzheimer Res; 2018; 15(12):1151-1160. PubMed ID: 30101708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corpus callosum atrophy rate in mild cognitive impairment and prodromal Alzheimer's disease.
    Elahi S; Bachman AH; Lee SH; Sidtis JJ; Ardekani BA;
    J Alzheimers Dis; 2015; 45(3):921-31. PubMed ID: 25633676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. When, where, and how the corpus callosum changes in MCI and AD: a multimodal MRI study.
    Di Paola M; Di Iulio F; Cherubini A; Blundo C; Casini AR; Sancesario G; Passafiume D; Caltagirone C; Spalletta G
    Neurology; 2010 Apr; 74(14):1136-42. PubMed ID: 20368633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corpus callosum atrophy associated with the degree of cognitive decline in patients with Alzheimer's dementia or mild cognitive impairment: a meta-analysis of the region of interest structural imaging studies.
    Wang XD; Ren M; Zhu MW; Gao WP; Zhang J; Shen H; Lin ZG; Feng HL; Zhao CJ; Gao K
    J Psychiatr Res; 2015 Apr; 63():10-9. PubMed ID: 25748753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hippocampal and Amygdalar Morphological Abnormalities in Alzheimer's Disease Based on Three Chinese MRI Datasets.
    Wei Y; Huang N; Liu Y; Zhang X; Wang S; Tang X
    Curr Alzheimer Res; 2020; 17(13):1221-1231. PubMed ID: 33602087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer's Disease Assessment Scale-Cognitive subscale variants in mild cognitive impairment and mild Alzheimer's disease: change over time and the effect of enrichment strategies.
    Podhorna J; Krahnke T; Shear M; Harrison JE;
    Alzheimers Res Ther; 2016 Feb; 8():8. PubMed ID: 26868820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regionally specific atrophy of the corpus callosum in AD, MCI and cognitive complaints.
    Wang PJ; Saykin AJ; Flashman LA; Wishart HA; Rabin LA; Santulli RB; McHugh TL; MacDonald JW; Mamourian AC
    Neurobiol Aging; 2006 Nov; 27(11):1613-7. PubMed ID: 16271806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Callosal circularity as an early marker for Alzheimer's disease.
    Van Schependom J; Niemantsverdriet E; Smeets D; Engelborghs S
    Neuroimage Clin; 2018; 19():516-526. PubMed ID: 29984160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Deformation-Based Shape Study of the Corpus Callosum in First Episode Schizophrenia.
    Huang W; Chen M; Lyu G; Tang X
    Front Psychiatry; 2021; 12():621515. PubMed ID: 34149469
    [No Abstract]   [Full Text] [Related]  

  • 10. Proposal of a Machine Learning Approach to Differentiate Mild and Alzheimer's Condition in MR Images Using Shape Changes in Corpus Callosum.
    Dadsena R; P R; Ramakrishnan S
    Stud Health Technol Inform; 2019; 258():243-244. PubMed ID: 30942758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Volumetric reduction of the corpus callosum in Alzheimer's disease in vivo as assessed with voxel-based morphometry.
    Chaim TM; Duran FL; Uchida RR; Périco CA; de Castro CC; Busatto GF
    Psychiatry Res; 2007 Jan; 154(1):59-68. PubMed ID: 17174533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation study of the Alzheimer's disease assessment scale-cognitive subscale (ADAS-Cog) for the Portuguese patients with mild cognitive impairment and Alzheimer's disease.
    Nogueira J; Freitas S; Duro D; Almeida J; Santana I
    Clin Neuropsychol; 2018; 32(sup1):46-59. PubMed ID: 29566598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inter-hemispheric functional dysconnectivity mediates the association of corpus callosum degeneration with memory impairment in AD and amnestic MCI.
    Qiu Y; Liu S; Hilal S; Loke YM; Ikram MK; Xu X; Yeow Tan B; Venketasubramanian N; Chen CL; Zhou J
    Sci Rep; 2016 Sep; 6():32573. PubMed ID: 27581062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the size and area of the corpus callosum with the Osiris method in Alzheimer's disease.
    Kabay SC; Gulbandilar E; Ozden H; Ozbag D; Guven G; Adapinar B; Durmaz R
    Neurodegener Dis; 2009; 6(4):148-53. PubMed ID: 19521062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The diffeomorphometry of regional shape change rates and its relevance to cognitive deterioration in mild cognitive impairment and Alzheimer's disease.
    Tang X; Holland D; Dale AM; Younes L; Miller MI;
    Hum Brain Mapp; 2015 Jun; 36(6):2093-117. PubMed ID: 25644981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo imaging of region and cell type specific neocortical neurodegeneration in Alzheimer's disease. Perspectives of MRI derived corpus callosum measurement for mapping disease progression and effects of therapy. Evidence from studies with MRI, EEG and PET.
    Hampel H; Teipel SJ; Alexander GE; Pogarell O; Rapoport SI; Möller HJ
    J Neural Transm (Vienna); 2002 May; 109(5-6):837-55. PubMed ID: 12111472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Splenium tract projections of the corpus callosum to the parietal cortex classifies Alzheimer's disease and mild cognitive impairment.
    Delvenne JF; Scally B; Rose Burke M
    Neurosci Lett; 2023 Jul; 810():137331. PubMed ID: 37302566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffusion tensor imaging measures of normal appearing white matter in patients who are aging, or have amnestic mild cognitive impairment, or Alzheimer's disease.
    Wang JH; Lv PY; Wang HB; Li ZL; Li N; Sun ZY; Zhao BH; Huang Y
    J Clin Neurosci; 2013 Aug; 20(8):1089-94. PubMed ID: 23787190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional shape abnormalities in mild cognitive impairment and Alzheimer's disease.
    Qiu A; Fennema-Notestine C; Dale AM; Miller MI;
    Neuroimage; 2009 Apr; 45(3):656-61. PubMed ID: 19280688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interhemispheric coupling improves the brain's ability to perform low cognitive demand tasks in Alzheimer's disease and high cognitive demand tasks in normal aging.
    Ansado J; Collins L; Joubert S; Fonov V; Monchi O; Brambati SM; Tomaiuolo F; Petrides M; Faure S; Joanette Y
    Neuropsychology; 2013 Jul; 27(4):464-80. PubMed ID: 23876119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.